Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1987 1
1991 2
1992 1
1993 2
1994 1
1995 4
1997 2
1998 6
1999 5
2000 6
2001 5
2002 4
2003 9
2004 11
2005 12
2006 10
2007 10
2008 31
2009 29
2010 19
2011 29
2012 29
2013 66
2014 59
2015 82
2016 88
2017 101
2018 102
2019 120
2020 157
2021 120
2022 93
Text availability
Article attribute
Article type
Publication date

Search Results

1,075 results
Results by year
Filters applied: . Clear all
Page 1
The role of necroptosis in cancer biology and therapy.
Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, Cheng H, Jin K, Ni Q, Yu X, Liu C. Gong Y, et al. Among authors: ni q. Mol Cancer. 2019 May 23;18(1):100. doi: 10.1186/s12943-019-1029-8. Mol Cancer. 2019. PMID: 31122251 Free PMC article. Review.
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.
Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, Qian Y, Huang Q, Ni Q, Liu C, Yu X. Luo G, et al. Among authors: ni q. Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188409. doi: 10.1016/j.bbcan.2020.188409. Epub 2020 Aug 19. Biochim Biophys Acta Rev Cancer. 2021. PMID: 32827580 Review.
Coronavirus Disease 2019 (COVID-19): A Perspective from China.
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Zu ZY, et al. Among authors: ni qq. Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21. Radiology. 2020. PMID: 32083985 Free PMC article. Review.
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.
Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, García Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira A, Gettinger SN, Tiseo M, Lin HM, Gupta N, Hanley MJ, Ni Q, Zhang P, Popat S. Camidge DR, et al. Among authors: ni q. J Clin Oncol. 2020 Nov 1;38(31):3592-3603. doi: 10.1200/JCO.20.00505. Epub 2020 Aug 11. J Clin Oncol. 2020. PMID: 32780660 Free PMC article. Clinical Trial.
Proton-driven transformable nanovaccine for cancer immunotherapy.
Gong N, Zhang Y, Teng X, Wang Y, Huo S, Qing G, Ni Q, Li X, Wang J, Ye X, Zhang T, Chen S, Wang Y, Yu J, Wang PC, Gan Y, Zhang J, Mitchell MJ, Li J, Liang XJ. Gong N, et al. Among authors: ni q. Nat Nanotechnol. 2020 Dec;15(12):1053-1064. doi: 10.1038/s41565-020-00782-3. Epub 2020 Oct 26. Nat Nanotechnol. 2020. PMID: 33106640 Free PMC article.
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.
Ma N, Wang YK, Xu S, Ni QZ, Zheng QW, Zhu B, Cao HJ, Jiang H, Zhang FK, Yuan YM, Zhang EB, Chen TW, Xia J, Ding XF, Chen ZH, Zhang XP, Wang K, Cheng SQ, Qiu L, Li ZG, Yu YC, Wang XF, Zhou B, Li JJ, Xie D. Ma N, et al. Among authors: ni qz. Nat Commun. 2021 May 24;12(1):3059. doi: 10.1038/s41467-021-23285-8. Nat Commun. 2021. PMID: 34031390 Free PMC article.
Exosomal microRNAs as tumor markers in epithelial ovarian cancer.
Pan C, Stevic I, Müller V, Ni Q, Oliveira-Ferrer L, Pantel K, Schwarzenbach H. Pan C, et al. Among authors: ni q. Mol Oncol. 2018 Nov;12(11):1935-1948. doi: 10.1002/1878-0261.12371. Epub 2018 Oct 9. Mol Oncol. 2018. PMID: 30107086 Free PMC article. Clinical Trial.
1,075 results